As the leading pharmaceutical excipients association in Europe, IPEC Europe has built working relationships throughout its history with a number of key international and European organisations.
The IPEC Federation is a global organisation that promotes quality in pharmaceutical excipients. The IPEC Federation represents the five existing regional International Pharmaceutical Excipient Councils (IPECs) - IPEC-Americas, IPEC Europe, IPEC Japan, IPEC China and IPEC India - and provides a unified voice to promote the best use of excipients in medicines as a means of improving patient treatment and safety.
Websites of other regional IPECs:
EXCiPACT is a not-for-profit organisation that develops and manages a high-quality, 3rd part certification scheme for producers, suppliers and distributors of pharmaceutical excipients.
The European Directorate for the Quality of Medicines & HealthCare (EDQM) of the Council of Europe has a central role in the quality of medicines and healthcare, including consumer health protection.
Created in 1964, the EDQM is a leading organisation that protects public health by enabling development, supporting implementation, and monitoring the application of quality standards for safe medicines and their safe use. Our standards are recognised as a scientific benchmark worldwide. The European Pharmacopoeia is legally binding in member states . Similarly, the EDQM develops guidance and standards in the areas of blood transfusion, organ transplantation and consumer health issues.
The World Health Organization (WHO) is the world’s leading organization devoted to the improvement of the health of the world’s nearly seven billion people.
Headquartered in Geneva, Switzerland, the World Health Organization is affiliated with the United Nations. Thousands of health experts around the world coordinate many programs to ensure that more people, and especially those living in dire poverty, have access to equitable, affordable care so that they can lead healthy, happy, and productive lives.
A sector group of CEFIC, APIC represents producers of APIs and API intermediates in Europe.
Its membership consists of more than 60 companies, located all over Europe, and of several national industry associations. APIC’s focus is on worldwide Quality, Good Manufacturing Practice (GMP) and Regulatory matters relating to APIs and intermediates.
European Paediatric Formulation Initiative (EuPFI) is a consortium working in a pre-competitive way on paediatric drug formulations.
Members are from academia, hospital pharmacies, pharmaceutical industry (Innovators, Generics,Contract Research Organizations (CRO), Specials and Excipient Manufacturers) with European Medicine Agency (EMA) as an observer.
It aims to expedite the development of better and safer medicines for children by identifying and scoping issues and challenges in paediatric formulation development.
It brings together the voluntary, academic, pharmaceutical industry, hospitals and regulatory agency in order to tackle the development of age appropriate formulation for paediatrics. It provides funding, expertise and resources to support the solutions to the problems and new technologies emerging from academic research.